Role of a paracrine action of mesenchymal stem cells in the improvement of left ventricular function after coronary artery occlusion in rats
- PMID: 17465776
- DOI: 10.2217/17460751.2.1.63
Role of a paracrine action of mesenchymal stem cells in the improvement of left ventricular function after coronary artery occlusion in rats
Abstract
Purpose: We aimed to determine whether soluble factors released by cultured mesenchymal stem cells (MSCs) improved cardiac function in an experimental model of myocardial infarction.
Methods: MSCs were cultured in fresh medium. The conditioned medium, which contained factors secreted by MSCs, was collected after 4 days of culture. Fischer rats with 1-week-old myocardial infarction were divided into four groups that received: saline (n = 12); fresh medium (n = 10); conditioned medium (n = 8); or 2 million MSCs in fresh medium (n = 10) by direct intramyocardial injection. A total of 4 weeks later, left ventricular (LV) function was assessed by LV angiogram and by LV catheterization. Hearts were processed for histology.
Results: Before treatment, LV angiogram assessment demonstrated that the baseline LV function was comparable among the four groups. At 4 weeks after treatment, LV angiogram and LV catheterization showed that LV ejection fraction was better in the fresh medium (49.5 +/- 1.0%), conditioned medium (48.5 +/- 2.1%) and MSCs groups (49.9 +/- 4.2%) than in the saline group (43.7 +/- 1.2%; p < 0.05). There were no significant differences in heart rate, blood pressure, postmortem LV volume, infarct size or septum thickness among the groups. The scar thickness was similar in the saline (395 +/- 31 microm), fresh medium (404 +/- 30 microm) and conditioned medium (397 +/- 34 microm) groups, but significantly thicker in the MSCs group (560 +/- 51 microm; p < 0.05).
Conclusion: Fresh medium, conditioned medium and MSC injection all improved LV function at 4 weeks after treatment compared with saline treatment in a rat myocardial infarct model; only MSCs increased wall thickness. Since the culture medium contains nutrients and bovine serum, the roles of the soluble factors released by MSCs might be masked. The effect of these nutrients needs further investigation.
Similar articles
-
Mesenchymal stem cells participate in angiogenesis and improve heart function in rat model of myocardial ischemia with reperfusion.Eur J Cardiothorac Surg. 2006 Aug;30(2):353-61. doi: 10.1016/j.ejcts.2006.02.070. Epub 2006 Jul 10. Eur J Cardiothorac Surg. 2006. PMID: 16829080
-
Soluble factors from multipotent mesenchymal stromal cells have antinecrotic effect on cardiomyocytes in vitro and improve cardiac function in infarcted rat hearts.Cell Transplant. 2012;21(5):1011-21. doi: 10.3727/096368911X623916. Epub 2012 Feb 2. Cell Transplant. 2012. PMID: 22305373
-
Intramyocardial injection of heart tissue-derived extracellular matrix improves postinfarction cardiac function in rats.J Cardiovasc Pharmacol Ther. 2013 May;18(3):270-9. doi: 10.1177/1074248412472257. Epub 2013 Jan 22. J Cardiovasc Pharmacol Ther. 2013. PMID: 23345062
-
Effects of hepatocyte growth factor overexpressed bone marrow-derived mesenchymal stem cells on prevention from left ventricular remodelling and functional improvement in infarcted rat hearts.Cell Biochem Funct. 2012 Oct;30(7):574-81. doi: 10.1002/cbf.2836. Epub 2012 May 16. Cell Biochem Funct. 2012. PMID: 22592978
-
Rational transplant timing and dose of mesenchymal stromal cells in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials.Stem Cell Res Ther. 2017 Jan 28;8(1):21. doi: 10.1186/s13287-016-0450-9. Stem Cell Res Ther. 2017. PMID: 28129790 Free PMC article.
Cited by
-
A G-CSF functionalized scaffold for stem cells seeding: a differentiating device for cardiac purposes.J Cell Mol Med. 2011 May;15(5):1096-108. doi: 10.1111/j.1582-4934.2010.01100.x. Epub 2010 Jun 1. J Cell Mol Med. 2011. PMID: 20518852 Free PMC article.
-
Focus on Extracellular Vesicles: Therapeutic Potential of Stem Cell-Derived Extracellular Vesicles.Int J Mol Sci. 2016 Feb 6;17(2):174. doi: 10.3390/ijms17020174. Int J Mol Sci. 2016. PMID: 26861305 Free PMC article. Review.
-
Mesenchymal stem cells as therapeutics and vehicles for gene and drug delivery.Adv Drug Deliv Rev. 2010 Sep 30;62(12):1156-66. doi: 10.1016/j.addr.2010.08.010. Epub 2010 Sep 7. Adv Drug Deliv Rev. 2010. PMID: 20828588 Free PMC article. Review.
-
Evaluating the Endocytosis and Lineage-Specification Properties of Mesenchymal Stem Cell Derived Extracellular Vesicles for Targeted Therapeutic Applications.Front Pharmacol. 2020 Mar 3;11:163. doi: 10.3389/fphar.2020.00163. eCollection 2020. Front Pharmacol. 2020. PMID: 32194405 Free PMC article.
-
Histopathological study of healing after allogenic mesenchymal stem cell delivery in myocardial infarction in dogs.J Histochem Cytochem. 2009 Feb;57(2):167-76. doi: 10.1369/jhc.2008.952507. Epub 2008 Nov 11. J Histochem Cytochem. 2009. PMID: 19001635 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical